A structural protein called vimentin may help drive cancer spread
In short: A review of cancer biology research describes vimentin, a protein normally found in mesenchymal cells, as a central driver of the epithelial-to-mesenchymal transition that lets cancer cells detach, migrate, resist treatment and evade the immune system. The authors argue vimentin both responds to and triggers this transition.
The review explains that vimentin filaments give migrating cells mechanical strength and flexibility, and switch on genes such as Snail, Slug, Twist and ZEB1/2 that push cells toward a more mobile, stem-cell-like state, making tumours harder to treat.
As a literature review rather than a new experiment, the paper synthesizes existing studies instead of testing vimentin directly, and the authors note more research is needed before considering it a treatment target.
Why it matters: Vimentin could be a useful target for future cancer therapies, though more direct research is needed.
Opens the Intellect+ feed with this card first. Swipe up for the next one.
Sources
- Source: Research: Usman et al. (2021). Vimentin Is at the Heart of Epithelial Mesenchymal Transition (EMT) Mediated Metastasis. Cancers. · cc-by
To cite this card, link to https://intellectplus.co.uk/app/science-research-the-protein-vimentin-plays-a-central-role-in-cancer-cell-mig.
How we source, check and correct cards: Editorial standards.
General information, not professional advice. Spotted an error? Flag the card or see corrections and complaints.
Intellect Plus is a visual educational discovery platform for exploring fascinating facts and ideas. Brain Food, Not Brain Rot. What is Intellect Plus?
Related
More in Cell biology · More in Science · Latest · A–Z · All topics